AKT1 and central nervous system cancer: In glioma and osteosarcoma, miR-1908-5p can target and inhibit the expression level of PTEN and promote the activation of the PI3K/Akt signaling pathway, thereby promoting cancer cell proliferation and angiogenesis (8, 9).